Longitudinal plasma measures of trimethylamine N‐oxide and risk of atherosclerotic cardiovascular disease events in community‐based older adults
Journal of the American Heart Association Aug 20, 2021
Lee Y, Nemet I, Wang Z, et al. - Higher risk of incident atherosclerotic cardiovascular disease (ASCVD: myocardial infarction, fatal coronary heart disease, stroke, sudden cardiac death, or other atherosclerotic death) was observed in relation to serial measures of trimethylamine N‐oxide (TMAO) in a large community‐based cohort of older US adults, and this relationship was apparently modified by presence of impaired renal function and with higher risk of recurrent ASCVD.
This study involved 4131 (incident) and 1449 (recurrent) older US adults.
To determine TMAO, stable isotope dilution liquid chromatography–tandem mass spectrometry was employed at baseline and 7 years.
TMAO is a gut microbiota‐dependent metabolite of dietary choline, L‐carnitine, and phosphatidylcholine‐rich foods.
Prospective follow‐up revealed occurrences of 1766 incident and 897 recurrent ASCVD events.
Higher risk of incident ASCVD was noted in relation to higher levels of TMAO, post- multivariable adjustment, with extreme quintile hazard ratio vs the lowest quintile = 1.21.
In cases with impaired renal function, high levels of TMAO were related to higher incidence of ASCVD; this was not seen in the presence of normal or mildly reduced renal function.
Participants with prior ASCVD showed a link of TMAO with higher risk of recurrent ASCVD, without significant modification by estimated glomerular filtration rate.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries